Jan K. Villadsen

Jan K. Villadsen has worked in the finance sector since 2009. From 2009-2016, they held the position of Underdirektør, Head of Debt Capital Markets at Nykredit Markets. In 2008 they were CFO at NatImmune A/S, majority owned by Novo Holdings. From 2009-2021, they held various positions as CFO and Financial Advisor at Neurokey, Gubra, Lactobio, Octarine, Inthera Bioscience AG, Pephexia Therapeutics ApS, and Asgard Therapeutics. Jan's roles included assisting the Management team and Board in financial affairs such as financing, management reporting, budgetting, forecasting, projections, and valuation.

Jan K. Villadsen attended Copenhagen Business School between 1990 and 1992, where they obtained a Graduate Diploma in Business Administration, International Business. Jan then returned to Copenhagen Business School between 1999 and 2001 to earn a Graduate Diploma in Business Administration, Organisation & Management.